Skip to main content

Generics

  • Report: DOJ subpoenas Sun Pharma over generics pricing

  • FDA approves Aurobindo’s generic Zomig
    SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo Pharma’s generic Zomig (zolmitriptan) tablets, the company announced Wednesday. The drug is indicated for acute treatment of migraine with or without aura in adults. 
     
    Aurobindo’s tablets will be available in 2.5- and 5-mg dosage strengths. The drug had sales of about $60.3 million in the U.s. for the 12 months ended March 2016, according to IMS Health. 
     

  • CVS Health’s Rx-free naloxone effort to reach 30 states by August
    WOONSOCKET, R.I. — CVS Health on Wednesday announced that its push to curb opioid overdose by providing overdose reversal drug naloxone without a prescription would hit 30 states by August through expansion to seven new states this summer. The initiative works by establishing a standing order with an in-state physician to allow pharmacists to dispense the drug to patients without individual prescriptions. The company has already begun dispensing naloxone in 23 states. 
     

  • FDA approves Ajanta’s generic Zomig
    SILVER SPRING, Md. — The Food and Drug Administration has approved Ajanta Pharma’s generic Zomig (zolmitriptan) tablets, the company announced Tuesday. 
     
    The drug is indicated for acute treatment of migraines and will be available in 2.5- and 5-mg dosage strengths. 

  • NYT: Opioid prescriptions drop for 1st time in 20 years

    The New York Times reports that the number of opioid prescriptions in the United States is falling for the first time since OxyContin hit the market in 1996. (New York Times)

  • Mylan launches first 200-mg Doryx generic
    PITTSBURGH — Mylan recently launched its generic of Doryx (doxycycline hyclate) 200-mg delayed-release tablets. The drug is indicated as an adjunctive treatment for severe acne. 
     
    Mylan will have 180 days of marketing exclusivity for the product, which had U.S. sales of about $181.8 million in the 12 months ended March 31, according to IMS Health.
     

  • FDA approves Aurobindo’s Tricor generic
    Dayton, N.J. — Aurobindo Pharma announced Friday that the Food and Drug Administration had approved its generic Tricor (fenofibrate) tablets. The drug is indicated to treat high cholesterol and high triglycerides. 
     
    Aurobindo’s fenofibrate tablets will be available in 48- and 145-mg dosage strength. The product had estimated U.S. sales of about $412.1 million for the twelve months ended March 2016, according to IMS Health. 
     

  • Report: Walgreens can now dispense naloxone without prescription in Lone Star State

    Texas is the latest state in which Walgreens can dispense naloxone without a prescription, according to a KUT.org published Thursday. Last year, advocates and public health experts convinced state lawmakers to pass Senate Bill 1462 in an effort to address the ongoing opioid epidemic. The bill was supposed to expand the availability of naloxone in Texas when it went into effect in September, but things have moved slowly, the news organization reported. On Wednesday, Alicia Kowalchuk with Baylor Medicine in Houston wrote a standing order for the medication for every Walgreens in the state.

X
This ad will auto-close in 10 seconds